Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Direct and indirect costs associated with stereotactic radiosurgery or open surgery for medial temporal lobe epilepsy: Results from the ROSE trial.

Langfitt JT, Quigg M, Yan G, Yu W, Ward MM, Barbaro NM, Chang EF, Broshek DK, Laxer KD, Cole AJ, Sneed PK, Hess C, Tripathi M, Heck CN, Miller JW, Garcia PA, McEvoy A, Fountain NB, Salanova V, Knowlton RC, Bagić A, Henry T, Kapoor S, McKhann G, Palade AE, Reuber M, Tecoma E; ROSE Trial Study Group.

Epilepsia. 2019 Jul;60(7):1453-1461. doi: 10.1111/epi.16072. Epub 2019 Jun 11.

PMID:
31185129
2.

Underdosing of Benzodiazepines in Patients With Status Epilepticus Enrolled in Established Status Epilepticus Treatment Trial.

Sathe AG, Tillman H, Coles LD, Elm JJ, Silbergleit R, Chamberlain J, Kapur J, Cock HR, Fountain NB, Shinnar S, Lowenstein DH, Conwit RA, Bleck TP, Cloyd JC.

Acad Emerg Med. 2019 Aug;26(8):940-943. doi: 10.1111/acem.13811. Epub 2019 Jul 18. No abstract available.

PMID:
31161706
3.

Visual field defects after radiosurgery versus temporal lobectomy for mesial temporal lobe epilepsy: Findings of the ROSE trial.

Quigg M, Barbaro NM, Ward MM, Chang EF, Broshek DK, Langfitt JT, Yan G, Laxer KD, Cole AJ, Sneed PK, Hess CP, Yu W, Newman SA, Mueller S, Tripathi M, Heck CN, Miller JW, Garcia PA, McEvoy A, Fountain NB, Salanova V, Knowlton RC, Bagić A, Henry T, Kapoor S, McKhann G, Palade AE, Reuber M, Tecoma E.

Seizure. 2018 Dec;63:62-67. doi: 10.1016/j.seizure.2018.10.017. Epub 2018 Oct 31.

PMID:
30408713
4.

Radiosurgery versus open surgery for mesial temporal lobe epilepsy: The randomized, controlled ROSE trial.

Barbaro NM, Quigg M, Ward MM, Chang EF, Broshek DK, Langfitt JT, Yan G, Laxer KD, Cole AJ, Sneed PK, Hess CP, Yu W, Tripathi M, Heck CN, Miller JW, Garcia PA, McEvoy A, Fountain NB, Salanova V, Knowlton RC, Bagić A, Henry T, Kapoor S, McKhann G, Palade AE, Reuber M, Tecoma E.

Epilepsia. 2018 Jun;59(6):1198-1207. doi: 10.1111/epi.14045. Epub 2018 Mar 30.

5.

Sudden unexpected death in epilepsy in patients treated with brain-responsive neurostimulation.

Devinsky O, Friedman D, Duckrow RB, Fountain NB, Gwinn RP, Leiphart JW, Murro AM, Van Ness PC.

Epilepsia. 2018 Mar;59(3):555-561. doi: 10.1111/epi.13998. Epub 2018 Jan 16.

6.

Indications and methodology for video-electroencephalographic studies in the epilepsy monitoring unit.

Shih JJ, Fountain NB, Herman ST, Bagic A, Lado F, Arnold S, Zupanc ML, Riker E, Labiner DM.

Epilepsia. 2018 Jan;59(1):27-36. doi: 10.1111/epi.13938. Epub 2017 Nov 10. Review.

7.

Earlier seizure onset and longer epilepsy duration correlate with the degree of temporal hypometabolism in patients with mesial temporal lobe sclerosis.

Leiva-Salinas C, Quigg M, Elias WJ, Patrie JT, Flors L, Fountain NB, Rehm PK.

Epilepsy Res. 2017 Dec;138:105-109. doi: 10.1016/j.eplepsyres.2017.10.023. Epub 2017 Oct 28.

PMID:
29100172
8.

Reducing placebo exposure in trials: Considerations from the Research Roundtable in Epilepsy.

Fureman BE, Friedman D, Baulac M, Glauser T, Moreno J, Dixon-Salazar T, Bagiella E, Connor J, Ferry J, Farrell K, Fountain NB, French JA.

Neurology. 2017 Oct 3;89(14):1507-1515. doi: 10.1212/WNL.0000000000004535. Epub 2017 Sep 6.

PMID:
28878049
9.

Brain-responsive neurostimulation in patients with medically intractable mesial temporal lobe epilepsy.

Geller EB, Skarpaas TL, Gross RE, Goodman RR, Barkley GL, Bazil CW, Berg MJ, Bergey GK, Cash SS, Cole AJ, Duckrow RB, Edwards JC, Eisenschenk S, Fessler J, Fountain NB, Goldman AM, Gwinn RP, Heck C, Herekar A, Hirsch LJ, Jobst BC, King-Stephens D, Labar DR, Leiphart JW, Marsh WR, Meador KJ, Mizrahi EM, Murro AM, Nair DR, Noe KH, Park YD, Rutecki PA, Salanova V, Sheth RD, Shields DC, Skidmore C, Smith MC, Spencer DC, Srinivasan S, Tatum W, Van Ness PC, Vossler DG, Wharen RE Jr, Worrell GA, Yoshor D, Zimmerman RS, Cicora K, Sun FT, Morrell MJ.

Epilepsia. 2017 Jun;58(6):994-1004. doi: 10.1111/epi.13740. Epub 2017 Apr 11.

10.

Brain-responsive neurostimulation in patients with medically intractable seizures arising from eloquent and other neocortical areas.

Jobst BC, Kapur R, Barkley GL, Bazil CW, Berg MJ, Bergey GK, Boggs JG, Cash SS, Cole AJ, Duchowny MS, Duckrow RB, Edwards JC, Eisenschenk S, Fessler AJ, Fountain NB, Geller EB, Goldman AM, Goodman RR, Gross RE, Gwinn RP, Heck C, Herekar AA, Hirsch LJ, King-Stephens D, Labar DR, Marsh WR, Meador KJ, Miller I, Mizrahi EM, Murro AM, Nair DR, Noe KH, Olejniczak PW, Park YD, Rutecki P, Salanova V, Sheth RD, Skidmore C, Smith MC, Spencer DC, Srinivasan S, Tatum W, Van Ness P, Vossler DG, Wharen RE Jr, Worrell GA, Yoshor D, Zimmerman RS, Skarpaas TL, Morrell MJ.

Epilepsia. 2017 Jun;58(6):1005-1014. doi: 10.1111/epi.13739. Epub 2017 Apr 7.

11.

Epilepsy matters: A research roundtable for epilepsy.

Fureman BE, Fountain NB, French JA.

Epilepsy Behav. 2016 Oct;63:123-124. doi: 10.1016/j.yebeh.2016.07.027. Epub 2016 Aug 25. No abstract available.

PMID:
27568912
12.

Circadian and ultradian patterns of epileptiform discharges differ by seizure-onset location during long-term ambulatory intracranial monitoring.

Spencer DC, Sun FT, Brown SN, Jobst BC, Fountain NB, Wong VS, Mirro EA, Quigg M.

Epilepsia. 2016 Sep;57(9):1495-502. doi: 10.1111/epi.13455. Epub 2016 Jul 11.

13.

Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials.

Biton V, Gil-Nagel A, Isojarvi J, Doty P, Hebert D, Fountain NB.

Epilepsy Behav. 2015 Nov;52(Pt A):119-27. doi: 10.1016/j.yebeh.2015.09.006. Epub 2015 Sep 27.

14.

Lateralization of mesial temporal lobe epilepsy with chronic ambulatory electrocorticography.

King-Stephens D, Mirro E, Weber PB, Laxer KD, Van Ness PC, Salanova V, Spencer DC, Heck CN, Goldman A, Jobst B, Shields DC, Bergey GK, Eisenschenk S, Worrell GA, Rossi MA, Gross RE, Cole AJ, Sperling MR, Nair DR, Gwinn RP, Park YD, Rutecki PA, Fountain NB, Wharen RE, Hirsch LJ, Miller IO, Barkley GL, Edwards JC, Geller EB, Berg MJ, Sadler TL, Sun FT, Morrell MJ.

Epilepsia. 2015 Jun;56(6):959-67. doi: 10.1111/epi.13010. Epub 2015 May 19.

15.

Interrater reliability in interpretation of electrocorticographic seizure detections of the responsive neurostimulator.

Quigg M, Sun F, Fountain NB, Jobst BC, Wong VS, Mirro E, Brown S, Spencer DC.

Epilepsia. 2015 Jun;56(6):968-71. doi: 10.1111/epi.12998. Epub 2015 Apr 20.

16.

Quality improvement in neurology: Epilepsy Update Quality Measurement Set.

Fountain NB, Van Ness PC, Bennett A, Absher J, Patel AD, Sheth KN, Gloss DS, Morita DA, Stecker M.

Neurology. 2015 Apr 7;84(14):1483-7. doi: 10.1212/WNL.0000000000001448. No abstract available.

17.

Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy.

Salanova V, Witt T, Worth R, Henry TR, Gross RE, Nazzaro JM, Labar D, Sperling MR, Sharan A, Sandok E, Handforth A, Stern JM, Chung S, Henderson JM, French J, Baltuch G, Rosenfeld WE, Garcia P, Barbaro NM, Fountain NB, Elias WJ, Goodman RR, Pollard JR, Tröster AI, Irwin CP, Lambrecht K, Graves N, Fisher R; SANTE Study Group.

Neurology. 2015 Mar 10;84(10):1017-25. doi: 10.1212/WNL.0000000000001334. Epub 2015 Feb 6.

18.

Safety and efficacy of adjunctive lacosamide among patients with partial-onset seizures in a long-term open-label extension trial of up to 8 years.

Rosenfeld W, Fountain NB, Kaubrys G, Ben-Menachem E, McShea C, Isojarvi J, Doty P; SP615 Study Investigators.

Epilepsy Behav. 2014 Dec;41:164-70. doi: 10.1016/j.yebeh.2014.09.074. Epub 2014 Oct 27.

PMID:
25461210
19.

A retrospective observational study of current treatment for generalized convulsive status epilepticus.

Langer JE, Fountain NB.

Epilepsy Behav. 2014 Aug;37:95-9. doi: 10.1016/j.yebeh.2014.06.008. Epub 2014 Jul 8.

PMID:
25010323
20.

Two-year seizure reduction in adults with medically intractable partial onset epilepsy treated with responsive neurostimulation: final results of the RNS System Pivotal trial.

Heck CN, King-Stephens D, Massey AD, Nair DR, Jobst BC, Barkley GL, Salanova V, Cole AJ, Smith MC, Gwinn RP, Skidmore C, Van Ness PC, Bergey GK, Park YD, Miller I, Geller E, Rutecki PA, Zimmerman R, Spencer DC, Goldman A, Edwards JC, Leiphart JW, Wharen RE, Fessler J, Fountain NB, Worrell GA, Gross RE, Eisenschenk S, Duckrow RB, Hirsch LJ, Bazil C, O'Donovan CA, Sun FT, Courtney TA, Seale CG, Morrell MJ.

Epilepsia. 2014 Mar;55(3):432-41. doi: 10.1111/epi.12534. Epub 2014 Feb 22.

21.

Out-of-body experiences associated with seizures.

Greyson B, Fountain NB, Derr LL, Broshek DK.

Front Hum Neurosci. 2014 Feb 13;8:65. doi: 10.3389/fnhum.2014.00065. eCollection 2014.

22.

Refractory status epilepticus: what to put down: the anesthetics or the patient?

Fountain NB, Fugate JE.

Neurology. 2014 Feb 25;82(8):650-1. doi: 10.1212/WNL.0000000000000008. Epub 2013 Dec 6. No abstract available.

PMID:
24319043
23.

De novo mutations in epileptic encephalopathies.

Epi4K Consortium; Epilepsy Phenome/Genome Project, Allen AS, Berkovic SF, Cossette P, Delanty N, Dlugos D, Eichler EE, Epstein MP, Glauser T, Goldstein DB, Han Y, Heinzen EL, Hitomi Y, Howell KB, Johnson MR, Kuzniecky R, Lowenstein DH, Lu YF, Madou MR, Marson AG, Mefford HC, Esmaeeli Nieh S, O'Brien TJ, Ottman R, Petrovski S, Poduri A, Ruzzo EK, Scheffer IE, Sherr EH, Yuskaitis CJ, Abou-Khalil B, Alldredge BK, Bautista JF, Berkovic SF, Boro A, Cascino GD, Consalvo D, Crumrine P, Devinsky O, Dlugos D, Epstein MP, Fiol M, Fountain NB, French J, Friedman D, Geller EB, Glauser T, Glynn S, Haut SR, Hayward J, Helmers SL, Joshi S, Kanner A, Kirsch HE, Knowlton RC, Kossoff EH, Kuperman R, Kuzniecky R, Lowenstein DH, McGuire SM, Motika PV, Novotny EJ, Ottman R, Paolicchi JM, Parent JM, Park K, Poduri A, Scheffer IE, Shellhaas RA, Sherr EH, Shih JJ, Singh R, Sirven J, Smith MC, Sullivan J, Lin Thio L, Venkat A, Vining EP, Von Allmen GK, Weisenberg JL, Widdess-Walsh P, Winawer MR.

Nature. 2013 Sep 12;501(7466):217-21. doi: 10.1038/nature12439. Epub 2013 Aug 11.

24.

Patient assessment of physician performance of epilepsy quality-of-care measures.

Wicks P, Fountain NB.

Neurol Clin Pract. 2012 Dec;2(4):335-342.

25.

Obliterating the Seizure Focus in AVMs is Effective: More Clinical Data Confirming Common Sense.

Fountain NB.

Epilepsy Curr. 2013 Jan;13(1):9-10. doi: 10.5698/1535-7511-13.1.9. No abstract available.

26.

Delivering quality care in epilepsy.

Fountain NB.

Curr Opin Neurol. 2013 Apr;26(2):174-8. doi: 10.1097/WCO.0b013e32835ee563. Review.

PMID:
23426379
27.

American Clinical Neurophysiology Society's Standardized Critical Care EEG Terminology: 2012 version.

Hirsch LJ, LaRoche SM, Gaspard N, Gerard E, Svoronos A, Herman ST, Mani R, Arif H, Jette N, Minazad Y, Kerrigan JF, Vespa P, Hantus S, Claassen J, Young GB, So E, Kaplan PW, Nuwer MR, Fountain NB, Drislane FW.

J Clin Neurophysiol. 2013 Feb;30(1):1-27. doi: 10.1097/WNP.0b013e3182784729. Review. No abstract available.

PMID:
23377439
28.

Standardized database development for EEG epileptiform transient detection: EEGnet scoring system and machine learning analysis.

Halford JJ, Schalkoff RJ, Zhou J, Benbadis SR, Tatum WO, Turner RP, Sinha SR, Fountain NB, Arain A, Pritchard PB, Kutluay E, Martz G, Edwards JC, Waters C, Dean BC.

J Neurosci Methods. 2013 Jan 30;212(2):308-16. doi: 10.1016/j.jneumeth.2012.11.005. Epub 2012 Nov 19.

PMID:
23174094
29.

Safety and tolerability of adjunctive lacosamide intravenous loading dose in lacosamide-naive patients with partial-onset seizures.

Fountain NB, Krauss G, Isojarvi J, Dilley D, Doty P, Rudd GD.

Epilepsia. 2013 Jan;54(1):58-65. doi: 10.1111/j.1528-1167.2012.03543.x. Epub 2012 Jun 18.

30.

Antiepileptic drug selection for partial-onset seizures.

Shneker BF, Fountain NB.

Curr Treat Options Neurol. 2012 Aug;14(4):356-68. doi: 10.1007/s11940-012-0186-5.

PMID:
22689063
31.

An unusual presentation of anti-Hu-associated paraneoplastic limbic encephalitis.

Langer JE, Lopes MB, Fountain NB, Pranzatelli MR, Thiele EA, Rust RS, Goodkin HP.

Dev Med Child Neurol. 2012 Sep;54(9):863-6. doi: 10.1111/j.1469-8749.2012.04221.x. Epub 2012 Feb 9.

32.

Quality improvement in neurology: AAN epilepsy quality measures: Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology.

Fountain NB, Van Ness PC, Swain-Eng R, Tonn S, Bever CT Jr; American Academy of Neurology Epilepsy Measure Development Panel and the American Medical Association-Convened Physician Consortium for Performance Improvement Independent Measure Development Process.

Neurology. 2011 Jan 4;76(1):94-9. doi: 10.1212/WNL.0b013e318203e9d1.

PMID:
21205698
33.

Pathophysiology and definitions of seizures and status epilepticus.

Huff JS, Fountain NB.

Emerg Med Clin North Am. 2011 Feb;29(1):1-13. doi: 10.1016/j.emc.2010.08.001. Review.

PMID:
21109098
34.

Examining the clinical utility of lacosamide: pooled analyses of three phase II/III clinical trials.

Chung S, Ben-Menachem E, Sperling MR, Rosenfeld W, Fountain NB, Benbadis S, Hebert D, Isojärvi J, Doty P.

CNS Drugs. 2010 Dec;24(12):1041-54. doi: 10.2165/11586830-000000000-00000.

PMID:
21090838
35.

Essential services, personnel, and facilities in specialized epilepsy centers--revised 2010 guidelines.

Labiner DM, Bagic AI, Herman ST, Fountain NB, Walczak TS, Gumnit RJ; National Association of Epilepsy Centers.

Epilepsia. 2010 Nov;51(11):2322-33. doi: 10.1111/j.1528-1167.2010.02648.x.

36.

Choosing among antiepileptic drugs.

Fountain NB.

Continuum (Minneap Minn). 2010 Jun;16(3 Epilepsy):121-35. doi: 10.1212/01.CON.0000368235.64857.cf.

PMID:
22810318
37.

Pharmacologic treatment of epilepsy.

Fountain NB, Cole AJ.

CNS Spectr. 2010 Mar;15(3 Suppl 5):4-6. No abstract available.

PMID:
20414176
38.

Should levetiracetam replace phenytoin for seizure prophylaxis after neurosurgery?

Fountain NB.

Epilepsy Curr. 2009 May-Jun;9(3):71-2. doi: 10.1111/j.1535-7511.2009.01297.x. No abstract available.

39.

A pregnant pause to consider teratogenicity of topiramate.

Fountain NB.

Epilepsy Curr. 2009 Mar-Apr;9(2):36-8. doi: 10.1111/j.1535-7511.2008.01284.x. No abstract available.

40.

A frontal assault on the generalized nature of juvenile myoclonic epilepsy.

Fountain NB.

Epilepsy Curr. 2008 Nov-Dec;8(6):152-3. doi: 10.1111/j.1535-7511.2008.00276.x. No abstract available.

41.

Evidence for functional impairment but not structural disease in benign rolandic epilepsy.

Fountain NB.

Epilepsy Curr. 2008 Jan-Feb;8(1):14-6. doi: 10.1111/j.1535-7511.2007.00220.x. No abstract available.

42.
43.

Is it time for routine EEG monitoring after intracerebral hemorrhage?

Fountain NB.

Neurology. 2007 Sep 25;69(13):1312-3. No abstract available.

PMID:
17893292
44.

Intravenous lacosamide as replacement for oral lacosamide in patients with partial-onset seizures.

Biton V, Rosenfeld WE, Whitesides J, Fountain NB, Vaiciene N, Rudd GD.

Epilepsia. 2008 Mar;49(3):418-24. Epub 2007 Sep 19.

45.

Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.

Fountain NB, Conry JA, Rodríguez-Leyva I, Gutierrez-Moctezuma J, Salas E, Coupez R, Stockis A, Lu ZS.

Epilepsy Res. 2007 Apr;74(1):60-9. Epub 2007 Jan 31.

PMID:
17270398
46.

EEG is an essential clinical tool: pro and con.

Fountain NB, Freeman JM.

Epilepsia. 2006;47 Suppl 1:23-5.

47.

Standardized mental status testing for nonconvulsive status epilepticus.

Kirby D, Fountain NB, Quigg M.

Am J Electroneurodiagnostic Technol. 2004 Sep;44(3):199-201. Review. No abstract available.

PMID:
15521471
48.
49.

Assessment of acute morbidity and mortality in nonconvulsive status epilepticus.

Shneker BF, Fountain NB.

Neurology. 2003 Oct 28;61(8):1066-73.

PMID:
14581666
50.

Epilepsy and athletics.

Fountain NB, May AC.

Clin Sports Med. 2003 Jul;22(3):605-16, x-xi. Review.

PMID:
12852689

Supplemental Content

Loading ...
Support Center